Dextran/eudragit S-100 based redox sensitive nanoparticles for colorectal cancer therapy
Aastha Gupta, Ankita Dhiman, Ankur Sood, Ravi Bharadwaj, Neal Silverman, Garima Agrawal
Abstract
biodistribution results demonstrate that DEEU NPs can remain in the colon region for up to 24 hours. These results indicate that DEEU NPs can act as a promising platform for colorectal cancer treatment.
Topics & Concepts
DextranColorectal cancerRedoxCancer therapyNanoparticleMaterials scienceMedicineNanotechnologyChemistryCancerChromatographyInternal medicineOrganic chemistryNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsGraphene and Nanomaterials Applications